Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2025-12-25 @ 3:38 AM
NCT ID: NCT03190902
Eligibility Criteria: Inclusion Criteria: * POMS diagnosed according to the most recent diagnostic criteria; * age \<18 years; * Expanded Disability Status Scale (EDSS) score ≤5.5; * impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values; * ADHD patients with the subtype inattention; * ADHD diagnosis performed according the DSM-5 criteria and the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention- Deficit/Hyperactivity Disorder (MTA) - Swanson, Nolan, and Pelham IV Rating Scale (MTA-SNAP-IV), Conner's Parent Rating Scale Revised (CPRS-R), Conner's Teacher Rating Scale Revised (CTRS-R), Child Behavior Checklist (CBCL), Kiddie Schedule for Affective Disorder and Schizophrenia (K-SADS); * age \<18 years; * impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values; Exclusion Criteria: * severe cognitive impairment (performance ≤2.0 SD of normative values); * severe visual loss (unable to read Times New Roman font 16 with the best correction); * major psychiatric illness; * alcohol or substance abuse; * education \<5 years; * previous cognitive rehabilitation training; * ongoing relapse or steroid treatment during the 30 days preceding enrollment; * ADHD subtype hyperactivity; * previously exposure or treatment with any psychotropic drug.
Healthy Volunteers: False
Sex: ALL
Maximum Age: 17 Years
Study: NCT03190902
Study Brief:
Protocol Section: NCT03190902